Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Schoenbaum

Showing results (1-10 of 112) with videos related to

Pageof 12
Sort By:
American Journal of Preventive Medicine|March 16, 2005
The accuracy of teens' expectations of future smokingMichael Schoenbaum
American Journal of Epidemiology|June 6, 2009
Invited Commentary: Assessing treatment effects by using observational analyses--opportunities and limitationsPhilip S Wang, Michael Schoenbaum
JAMA Psychiatry|December 18, 2014
Benzodiazepine use in the United StatesMark Olfson, Marissa King, Michael Schoenbaum
Journal of Affective Disorders|July 12, 2005
Gender patterns in cost effectiveness of quality improvement for depression: results of a randomized, controlled trialMichael Schoenbaum, Cathy Sherbourne, Kenneth Wells
Journal of Child and Adolescent Psychopharmacology|March 17, 2016
Stimulant Treatment of Young People in the United StatesMark Olfson, Marissa King, Michael Schoenbaum
JAMA Psychiatry|July 2, 2015
Treatment of Young People With Antipsychotic Medications in the United StatesMark Olfson, Marissa King, Michael Schoenbaum
The Journal of Clinical Psychiatry|November 4, 2015
Antipsychotic treatment of adults in the United StatesMark Olfson, Marissa King, Michael Schoenbaum
Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention|July 15, 2024
Trends in mortality after emergency department presentation for suicidal behaviour in CaliforniaSidra Goldman-Mellor, Mark Olfson, Michael Schoenbaum
Drug and Alcohol Dependence|May 1, 2022
Acute injury mortality and all-cause mortality following emergency department presentation for alcohol use disorderSidra Goldman-Mellor, Mark Olfson, Michael Schoenbaum
Health Affairs (Project Hope)|June 2, 2020
Buprenorphine Treatment By Primary Care Providers, Psychiatrists, Addiction Specialists, And OthersMark Olfson, Victoria Zhang, Michael Schoenbaum, et al.
Pageof 12

Showing results (1-10 of 112) with videos related to

Sort By:
Pageof 12
American Journal of Preventive Medicine|March 16, 2005
The accuracy of teens' expectations of future smokingMichael Schoenbaum
American Journal of Epidemiology|June 6, 2009
Invited Commentary: Assessing treatment effects by using observational analyses--opportunities and limitationsPhilip S Wang, Michael Schoenbaum
JAMA Psychiatry|December 18, 2014
Benzodiazepine use in the United StatesMark Olfson, Marissa King, Michael Schoenbaum
Journal of Affective Disorders|July 12, 2005
Gender patterns in cost effectiveness of quality improvement for depression: results of a randomized, controlled trialMichael Schoenbaum, Cathy Sherbourne, Kenneth Wells
Journal of Child and Adolescent Psychopharmacology|March 17, 2016
Stimulant Treatment of Young People in the United StatesMark Olfson, Marissa King, Michael Schoenbaum
JAMA Psychiatry|July 2, 2015
Treatment of Young People With Antipsychotic Medications in the United StatesMark Olfson, Marissa King, Michael Schoenbaum
The Journal of Clinical Psychiatry|November 4, 2015
Antipsychotic treatment of adults in the United StatesMark Olfson, Marissa King, Michael Schoenbaum
Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention|July 15, 2024
Trends in mortality after emergency department presentation for suicidal behaviour in CaliforniaSidra Goldman-Mellor, Mark Olfson, Michael Schoenbaum
Drug and Alcohol Dependence|May 1, 2022
Acute injury mortality and all-cause mortality following emergency department presentation for alcohol use disorderSidra Goldman-Mellor, Mark Olfson, Michael Schoenbaum
Health Affairs (Project Hope)|June 2, 2020
Buprenorphine Treatment By Primary Care Providers, Psychiatrists, Addiction Specialists, And OthersMark Olfson, Victoria Zhang, Michael Schoenbaum, et al.
Pageof 12